Results 281 to 290 of about 133,872 (296)

Enzyme Replacement Therapy for Mucopolysaccharidoses: Opinions of Patients and Families

Journal of Pediatrics, 2008
David Coman, Veronica Collins, J Ed Wraith   +2 more
exaly  

ENZYME REPLACEMENT THERAPY IN MPS1

Neuropediatrics, 2006
L De Meirleir, A Benatar, A Van Hulle, G Van Berlaer   +3 more
openaire   +1 more source

Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: A pilot study

Kidney International, 2004
Vincenzo Panichi, Daniele Taccola, Francesca Boscaro   +2 more
exaly  

Does early use of enzyme replacement therapy alter the natural history of mucopolysaccharidosis I? Experience in three siblings

Molecular Genetics and Metabolism, 2013
Catherine Breen, Jean Mercer, Simon Jones   +2 more
exaly  

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age–a sibling control study

Clinical Genetics, 2010
David Coman, J J Hopwood
exaly  

Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE

Journal of Controlled Release, 2009
Jo A Van Ginderachter, Wim Versees, Patrick Van Gelder   +2 more
exaly  

Enzyme Replacement Therapy

2008
openaire   +1 more source

Hormone replacement therapy in cancer survivors: a con opinion

Ca-A Cancer Journal for Clinicians, 1996
Carolyn D Runowicz
exaly  

Clinical Consequences of Interrupting Enzyme Replacement Therapy in Children with Type 1 Gaucher Disease

Journal of Pediatrics, 2007
exaly  

Comparative Efficacy of Dose Regimens in Enzyme Replacement Therapy of Type I Gaucher Disease

Blood Cells, Molecules, and Diseases, 2000
Gheona Altarescu, Raphaël Schiffmann, D F Moore   +2 more
exaly